| Symbol |
Name |
|
ADAM28
|
ADAM metallopeptidase domain 28
|
|
ADAMDEC1
|
ADAM-like, decysin 1
|
|
ADCK3
|
aarF domain containing kinase 3
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AIM1
|
absent in melanoma 1
|
|
AK1
|
adenylate kinase 1
|
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E
|
|
ATM
|
ATM serine/threonine kinase
|
|
BLVRA
|
biliverdin reductase A
|
|
BTD
|
biotinidase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
|
CD200
|
CD200 molecule
|
|
CIAPIN1
|
cytokine induced apoptosis inhibitor 1
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DTYMK
|
deoxythymidylate kinase (thymidylate kinase)
|
|
FGL2
|
fibrinogen-like 2
|
|
FHL1
|
four and a half LIM domains 1
|
|
FKTN
|
fukutin
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GPR171
|
G protein-coupled receptor 171
|
|
GPR19
|
G protein-coupled receptor 19
|
|
HCAR3
|
hydroxycarboxylic acid receptor 3
|
|
HEXA
|
hexosaminidase A (alpha polypeptide)
|
|
HFE
|
hemochromatosis
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNG
|
interferon, gamma
|
|
IL1B
|
interleukin 1, beta
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
JCHAIN
|
joining chain of multimeric IgA and IgM
|
|
KDR
|
kinase insert domain receptor
|
|
KRT86
|
keratin 86, type II
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LYZ
|
lysozyme
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MYO1D
|
myosin ID
|
|
NINL
|
ninein-like
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PLA2G16
|
phospholipase A2, group XVI
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PSKH1
|
protein serine kinase H1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPRM
|
protein tyrosine phosphatase, receptor type, M
|
|
RANBP3
|
RAN binding protein 3
|
|
RBM25
|
RNA binding motif protein 25
|
|
SEC23IP
|
SEC23 interacting protein
|
|
SEPHS2
|
selenophosphate synthetase 2
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SLC5A3
|
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3
|
|
ST5
|
suppression of tumorigenicity 5
|
|
STK4
|
serine/threonine kinase 4
|
|
TBC1D31
|
TBC1 domain family, member 31
|
|
TIMELESS
|
timeless circadian clock
|
|
TLR2
|
toll-like receptor 2
|
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TRIM22
|
tripartite motif containing 22
|
|
VEGFA
|
vascular endothelial growth factor A
|